Red Light vs Near-Infrared: What’s the Difference?
When researching light therapy or comparing devices for your wellness routine, you will inevitably encounter a confusing mix of terms and numbers: red light, near-infrared (NIR), 660 nm, 810 nm, and 850 nm. Because these terms are frequently grouped together, a common question naturally arises: are red light and near-infrared light the same thing?
The short answer is no. While they are neighboring parts of the electromagnetic spectrum and share similar underlying scientific principles, they are not interchangeable. Their distinct physical properties change how they interact with the human body.
To genuinely understand how these technologies work, it is necessary to look at what separates red light from near-infrared light, why wavelength matters, and why neither category can simply be labeled as universally "better."
The Light Spectrum: Visible vs. Invisible
To understand the difference between red light and near-infrared light, we must first look at how light is measured. Light travels in waves, and the distance between the peaks of these waves is called a wavelength. Wavelengths are measured in nanometers (nm), and this measurement determines where a specific type of light sits on the electromagnetic spectrum.
Red light falls within the visible part of the spectrum, typically ranging from about 600 nm to 700 nm. Because it is within the visible spectrum, the human eye perceives these wavelengths as the color red. Common wavelengths used in research include 660 nm and 670 nm, which is heavily studied in areas like retinal energy metabolism.
Near-infrared (NIR) light sits just outside the visible spectrum, ranging from about 700 nm up to 1,100 nm. The human eye cannot see near-infrared light. Even though a device emitting NIR might look completely dark or give off only a faint glow (often due to secondary visible emissions from the LEDs), the light energy is still present and active. Common near-infrared wavelengths include 810 nm and 850 nm.
The core distinction is simple: red light is visible, and near-infrared light is invisible. However, this shift in wavelength does much more than change what our eyes can see—it fundamentally alters how the light behaves when it hits biological tissue.
How Light Interacts with the Body: Absorption and Scattering
When light touches the skin, it does not simply stop at the surface. It enters the tissue, where it experiences two primary optical events: absorption and scattering.
Absorption occurs when biological structures (like water, melanin, hemoglobin, and specific cellular components) absorb the light's energy. Scattering occurs when the light bounces off cells and structures, forcing it to change direction and spread out as it moves through the tissue.
Wavelength dictates how much a beam of light will be absorbed or scattered. In the science of photobiomodulation (PBM), the red and near-infrared wavelengths sit in what researchers call the "optical window" of tissue. In this specific range (roughly 600 nm to 1,100 nm), absorption by water and melanin is relatively low, allowing the light to enter the body rather than being immediately blocked at the skin layer.
However, red light and NIR do not travel through tissue in the exact same way.
Visible red wavelengths (like 660 nm) experience a higher degree of scattering and absorption by blood (specifically hemoglobin) and melanin. Because the light is absorbed and scattered more quickly, it tends to stay closer to the surface.
Near-infrared wavelengths (like 810 nm and 850 nm) experience significantly less scattering. With less interference, NIR light can travel on a more direct path, giving it a general tendency to penetrate further through biological tissue than visible red light.
Does Deeper Penetration Mean "Better"?
Because near-infrared light generally penetrates farther through tissue, a common misconception is that NIR is automatically "stronger" or "better" than red light. In photobiomodulation, effectiveness is not determined solely by depth.
The goal of PBM is to deliver light energy to a specific target. If the target is superficial—such as the skin, superficial blood vessels, or shallow tissue layers—visible red light is highly efficient precisely because it is absorbed rapidly in these areas. Passing straight through the target tissue without being absorbed would defeat the purpose.
Conversely, if the research target involves deeper structures—such as deeper muscles, joints, or bone—near-infrared light is often utilized because its reduced scattering allows more photons to reach those depths.
Furthermore, wavelength is only one part of a highly complex equation. Research consistently demonstrates that PBM outcomes rely heavily on other delivery parameters, including irradiance (the intensity of the light), the total dose (the amount of energy delivered over time), and the specific exposure conditions. A deep-penetrating wavelength delivered at an incorrect dose will not yield optimal results.
Cellular Targets: How Both Wavelengths Power the Body
Despite their differences in penetration, red and near-infrared light share a common foundation in how they affect cells. A primary area of research explaining the mechanisms of PBM focuses on mitochondria, often referred to as the powerhouses of the cell.
Within the mitochondria is an enzyme called cytochrome c oxidase (CCO). Research suggests that CCO acts as a photoacceptor—a molecule that can absorb light particles (photons). Both visible red and near-infrared wavelengths are absorbed by CCO.
When this absorption occurs, it is believed to stimulate a cascade of cellular events, leading to increased production of adenosine triphosphate (ATP), which is cellular energy. This process also briefly alters reactive oxygen species (ROS) and releases nitric oxide (NO), triggering further signaling pathways related to cellular repair and metabolism.
While CCO is an important and widely studied mechanism, it is not the only one. Other light-sensitive proteins and pathways, particularly concerning how NIR interacts with cellular water structures, are also active areas of scientific investigation. The key takeaway is that both red and NIR wavelengths are biologically active and capable of triggering these cellular responses; they simply do so at different depths and absorption rates.
Why Systems Combine Red and Near-Infrared Light
When examining modern PBM devices or clinical research setups, you will often find systems that utilize both red and near-infrared wavelengths simultaneously.
This is not a matter of one wavelength compensating for the other's weakness, but rather an engineering and research rationale aimed at covering a broader volume of tissue. By combining a visible red wavelength (like 660 nm) with a near-infrared wavelength (like 850 nm), a device can rapidly target superficial receptors and skin layers while simultaneously delivering energy to deeper tissues.
This combination allows for a more comprehensive distribution of light energy throughout the tissue matrix. Different wavelengths may be selected or combined depending entirely on the specific research goals or the intended application of the device design.
Conclusion: Making Sense of Wavelengths
Ultimately, evaluating red light versus near-infrared is not about deciding which is universally "better." Wavelength simply determines how light travels through and interacts with biological tissue. Effective photobiomodulation comes down to matching the right wavelength—or combining multiple wavelengths—with the correct target tissue, supported by proper irradiance and dosage. By understanding this distinction, you can evaluate light therapy technologies more clearly and choose the solution that genuinely aligns with your specific needs.
References
[1] Jacques SL. Optical properties of biological tissues: a review. Phys Med Biol.